Skip to main content

RA CAPITAL MANAGEMENT, L.P.

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1346824 BOSTON, MA

Position in SPRY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$87,213,645
-$39,316,737 QoQ
Shares Held
10,860,977
0.0% QoQ
Ownership
10.9%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RA CAPITAL MANAGEMENT, L.P. holds $9,134,713,488 across 74 Biotechnology names. SPRY ranks #23 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SPRY

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $87,213,645 10,860,977
2025-12-31 $126,530,382 10,860,977
2025-09-30 $109,152,818 10,860,977
2025-09-29 $106,346,296 10,940,977
2025-06-30 $189,524,048 10,860,977
2025-03-31 $136,631,090 10,860,977
2024-12-31 $114,583,307 10,860,977
2024-09-30 $157,484,166 10,860,977
2024-06-30 $92,426,914 10,860,977
2023-12-31 $51,839,035 9,459,678
2023-06-30 $20,164,842 3,009,678
2023-03-31 $19,593,003 3,009,678
2022-12-31 $25,672,553 3,009,678
2021-12-31 $11,602,958 1,742,186
2021-09-30 $17,387,016 1,742,186
2021-06-30 $53,816,125 1,742,186
2021-03-31 $76,011,575 1,742,186
2020-12-31 $80,732,899 1,742,186